Previous studies [25,44], including work from our group [6,7,8], demonstrated that immunoadjuvants like anti-CD40 induce antitumor effects in different cancer models, including the lung, while apoptosis induced by radiation initiates further enhancement of immune cell activation [6,7]. This evidence concerns the gene CD40 and cancer.